Abstract
The large-scale Diabetes Control and Complication Trial (DCCT) has convincingly demonstrated the benefits of intensive therapy on diabetic nephropathy, neuropathy, and retinopathy [1]. A meta-analysis of several smaller studies also reached the same conclusions on nephropathy and retinopathy [2]. Decades of debate over whether normalization of hyperglycaemia may retard or delay microvascular complications came to an end [3, 4]. As more randomized-controlled trials in diabetic patients are being conducted, meta-analysis will be a useful tool to study interventions in the prevention of diabetic complications. In this chapter, we review the principle, strengths, and limitations of meta-analysis and the results of meta-analysis of intensive glycaemic control on diabetic nephropathy. The clinical implications of intensive therapy, based on the results of DCCT and meta-analysis, are also discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–986.
Wang PH, Lau J, Chalmers CT. Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet 1993; 341: 1306–1309.
Wang PH. Tight blood glucose control and diabetic complications. Lancet 1993; 342: 617–618.
Lasker RD. The diabetes control and complications trial-implications for policy and practice. N Engl J Med 1993; 329: 1053–1054.
Sacks HS, Berner J, Reitman D, Ancona-Berk VA, Chalmers TC. Meta-analyses of randomized controlled trials. N Engl J Med 1987; 316: 450–455.
L’Abbe KA, Detsky AS, O’Rourke. Meta-analysis in clinical research. Ann Intern Med 1987; 107: 224–233.
Liberati A, Himel HN, Chalmers TC. A quality assessment of randomized control trials of primary treatment of breast cancer. J Clin Oncol 1986; 4: 962–951.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986; 7: 177–188.
Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992; 327: 248–254.
Antman EM, Lau J, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts: treatment for myocardial infarction. JAMA 1992; 268: 240–248.
Rosenthal R. The »file drawer problem« and tolerance for null results. Psychol Bull 1979; 86: 638–641.
The Kroc Collaborative Study Group. Blood glucose control and the evolution of diabetic retinopathy and albuminuria. N Engl J Med 1984; 311: 365–372.
Deckert T, Lauritzen T, Parving HH, Christiansen JS, Steno Study Group. Effect of two years of strict metabolic functions in long term insulin-dependent diabetics. Diabetic Nephropathy 1984; 3: 6–10.
Wiseman MJ, Saunders AJ, Keen H, Viberti G. Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N Engl J Med 1985; 312: 617–621.
Beck-Nielsen H, Richelsen B, Mogensen CE, et al. Effect of insulin pump treatment for one year on renal function and retinal morphology in patients with IDDM. Diabetes Care 1985; 312: 617–621.
Feldt-Rasmussen B, Mathiesen ER, Deckert T. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet 1986; 2: 1300–1304.
Christensen CK, Christiansen JS, Schmitz A, et al. Effect of continuous subcutaneous insulin infusion on kidney function and size in IDDM patients: a 2 year controlled study. J Diabetic Complications 1987; 1: 91–95.
Dahl-Jørgensen K, Hanssen KF, Kierulf P, Bjøro T, Sandvik L, Aagenæs Ø. Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. Acta Endocrinol (Copenh) 1988; 117: 19–25.
Reichard P, Berglund B, Britz A, Cars I, Nilsson BY, Rosenqvist U. Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years. J Intern Med 1991; 230: 101–108.
Holman RR, Dornan TL, Mayon-White V, et al. Prevention of deterioration of renal and sensory nerve function by more intensive management of insulin-dependent diabetic patients. Lancet 1983; 1: 204–207.
Lestradet H, Papoz L, Hellouis De Menibus C, et al. Long-term study of mortality and vascular complications in juvenile-onset (type I) diabetes. Diabetes 1981; 30: 175–179.
Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311: 89–93.
Wang PH, Lau J, Chalmers TC. Meta-analysis of the effects of intensive glycemic control on late complications of type I diabetes mellitus. Online J Curr Clin Trials 1993 May 21; Doc No 60.
Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984; 102: 527–532.
Unger RH, Foster DW. Diabetes mellitus. In: Wilson JD, Foster DW (eds). Williams Textbook of Endocrinology. Philadelphia: W.B. Saunders; 1992; pp 1255–1333.
Karam JH, Salber PR, Forsham PH. Pancreatic hormones and diabetes mellitus. In: Greenspan FS (ed). Basic and Clinical Endocrinology. East Norwalk: Appleton & Lange; 1991; pp 592–650.
Boden G, Reichard GA Jr, Hoeldtke RD, et al. Severe insulin-induced hypoglycaemia associated with deficiencies in the release of counterregulatory hormones. N Engl J Med 1981; 305: 1200–1205.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wang, P.H., Lau, J., Chalmers, T.C. (1994). Meta-Analysis of the Effect of Intensive Therapy on Nephropathy in Type I Diabetes Mellitus. In: Mogensen, C.E. (eds) The Kidney and Hypertension in Diabetes Mellitus. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6746-9_34
Download citation
DOI: https://doi.org/10.1007/978-1-4757-6746-9_34
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-6748-3
Online ISBN: 978-1-4757-6746-9
eBook Packages: Springer Book Archive